Literature DB >> 11846418

Insulin stimulates nitric oxide production in rat adipocytes.

Catherine Ribière1, Anne-Marie Jaubert, Dominique Sabourault, Danièle Lacasa, Yves Giudicelli.   

Abstract

In adipocytes, insulin regulates the activity of different protein kinases (PI3K/Akt, MAPK, PKC) and protein phosphatases (PP-1, PP-2A). Since these enzymes are implicated in the regulation of NOS activity which is present in adipose tissue, we tested the effects of insulin on white adipocyte NOS activity. Exposure of adipocytes to insulin resulted simultaneously in NOS activity stimulation and Akt activation with maximal effect observed at 1 nM. Higher concentrations of insulin induced a progressive decline of NOS activity. In the presence of wortmannin, a PI3K inhibitor, 1 nM insulin failed to stimulate NOS activity. Insulin (1 nM)-stimulated NOS activity was also abolished by U0126, an inhibitor of p42/p44 MAPK activation, and by 1 microM okadaic acid (OA), which inhibits both PP-1 and PP-2A but not by 1 nM OA which inhibits only PP-2A. Moreover, inhibition of cPKC allowed a high (1 microM) insulin concentration to stimulate NOS activity. These results (i) demonstrate that insulin activates NO production in adipocytes through both PI3K/Akt and MAPK/PP-1 activation and (ii) suggest that PP-1 activation protects NOS against the inhibitory effect of cPKC activation. ©2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11846418     DOI: 10.1006/bbrc.2002.6444

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Targeting the NO/superoxide ratio in adipose tissue: relevance to obesity and diabetes management.

Authors:  Aleksandra Jankovic; Aleksandra Korac; Biljana Buzadzic; Ana Stancic; Vesna Otasevic; Péter Ferdinandy; Andreas Daiber; Bato Korac
Journal:  Br J Pharmacol       Date:  2016-05-15       Impact factor: 8.739

2.  Insulin-induced electrophysiology changes in human pleura are mediated via its receptor.

Authors:  V K Kouritas; M Ioannou; C N Foroulis; N Desimonas; K Evaggelopoulos; K I Gourgoulianis; P A Molyvdas; C Hatzoglou
Journal:  Exp Diabetes Res       Date:  2010-08-12

3.  A Dietary Supplement Containing Cinnamon, Chromium and Carnosine Decreases Fasting Plasma Glucose and Increases Lean Mass in Overweight or Obese Pre-Diabetic Subjects: A Randomized, Placebo-Controlled Trial.

Authors:  Yuejun Liu; Aurélie Cotillard; Camille Vatier; Jean-Philippe Bastard; Soraya Fellahi; Marie Stévant; Omran Allatif; Clotilde Langlois; Séverine Bieuvelet; Amandine Brochot; Angèle Guilbot; Karine Clément; Salwa W Rizkalla
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.